Intrathecal PACAP-38 causes increases in sympathetic nerve activity and heart rate but not blood pressure in the spontaneously hypertensive rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 1, 2011, Pages

  Farnham, Melissa M J ^a   Inglott, Melissa A ^a   Pilowsky, Paul M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Pituitary adenylate cyclase activating polypeptide; Spinal cord; Sympathetic activity

Indexed keywords

BLOCKING AGENT; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 6 38; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GRANULOCYTIC SARCOMA; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SPINAL ANESTHESIA; SYMPATHETIC NERVE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; FLUORESCENT ANTIBODY TECHNIQUE; HEART RATE; HYPERTENSION; IN SITU HYBRIDIZATION; INJECTIONS, SPINAL; MEDULLA OBLONGATA; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RNA, MESSENGER; SPECIES SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA; TYROSINE 3-MONOOXYGENASE; VASODILATOR AGENTS;

EID: 78651337689     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00662.2010     Document Type: Article

References (51)

1. Beaudet MM, Parsons RL, Braas KM, May V. Mechanisms mediating pituitary adenylate cyclase-activating polypeptide depolarization of rat sympathetic neurons. J Neurosci 20: 7353-7361, 2000.
2. Brown DL, Guyenet PG. Electrophysiological study of cardiovascular neurons in the rostral ventrolateral medulla in rats. Circ Res 56: 359-369, 1985.
3. Buscail L, Gourlet P, Cauvin A, De Neef P, Gossen D, Arimura A, Miyata A, Coy DH, Robberecht P, Christophe J. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett 262: 77-81, 1990.
4. Cauvin A, Buscail L, Gourlet P, De Neef P, Gossen D, Arimura A, Miyata A, Coy DH, Robberecht P, Christophe J. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 11: 773-777, 1990.
5. Cauvin A, Robberecht P, De Neef P, Gourlet P, Vandermeers A, Vandermeers-Piret MC, Christophe J. Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord. Regul Pept 35: 161-173, 1991.
6. Das M, Vihlen CS, Legradi G. Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J Comp Neurol 500: 761-776, 2007.
7. Dickinson T, Fleetwood-Walker SM, Mitchell R, Lutz EM. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs. Neuropeptides 31: 175-185, 1997.
8. Dickson L, Finlayson K. VPAC and PAC receptors: from ligands to function. Pharmacol Ther 121: 294-316, 2009.
9. Durr K, Norsted E, Gomuc B, Suarez E, Hannibal J, Meister B. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) defines a subpopulation of hypothalamic POMC neurons. Brain Res 1186: 203-211, 2007.
10. Farnham MMJ, Li Q, Goodchild AK, Pilowsky PM. PACAP is expressed in sympathoexcitatory bulbospinal C1 neurons of the brain stem and increases sympathetic nerve activity in vivo. Am J Physiol Regul Integr Comp Physiol 294: R1304-R1311, 2008.
11. Fizanne L, Sigaudo-Roussel D, Saumet JL, Fromy B. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents. J Physiol 554: 519-528, 2004.
12. Ghzili H, Grumolato L, Thouennon E, Tanguy Y, Turquier V, Vaudry H, Anouar Y. Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol 29: 128-141, 2008.
13. Gray SL, Yamaguchi N, Vencova P, Sherwood NM. Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology 143: 3946-3954, 2002.
14. Green BD, Irwin N, Cassidy RS, Gault VA, Flatt PR. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice. Peptides 27: 2343-2349, 2006.
15. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
16. Hamelink C, Tjurmina O, Damadzic R, Young WS, Weihe E, Lee HW, Eiden LE. Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci USA 99: 461-466, 2002.
17. Hannibal J. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 453: 389-417, 2002.
18. Hannibal J, Ding JM, Chen D, Fahrenkrug J, Larsen PJ, Gillette MU, Mikkelsen JD. Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci 17: 2637-2644, 1997.
19. Hannibal J, Mikkelsen JD, Clausen H, Holst JJ, Wulff BS, Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus (Abstract). Regul Pept 55: 133, 1995.
20. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50: 265-270, 1998. (Pubitemid 28304027)
21. Hautmann M, Friis UG, Desch M, Todorov V, Castrop H, Segerer F, Otto C, Schutz G, Schweda F. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors. J Am Soc Nephrol 18: 1150-1156, 2007.
22. Ito S, Komatsu K, Tsukamoto K, Sved AF. Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. Hypertension 35: 413-417, 2000.
23. Krieger EM. Neurogenic hypertension in the rat. Circ Res 15: 511-521, 1964.
24. Kuri BA, Chan SA, Smith CB. PACAP regulates immediate catecholamine release from adrenal chromaffin cells in an activity-dependent manner through a protein kinase C-dependent pathway. J Neurochem 110: 1214-1225, 2009.
25. Kyeung MJ, Yoon HC, Min KK, Ryoung HN, Byung LL, Kyung HL, Choong IC. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 476: 388-413, 2004.
26. Lai CC, Wu SY, Lin HH, Dun NJ. Excitatory action of pituitary adenylate cyclase activating polypeptide on rat sympathetic preganglionic neurons in vivo and in vitro (Abstract). Brain Res 748: 189, 1997.
27. Li Q, Goodchild AK, Seyedabadi M, Pilowsky PM. Pre-protachykinin A mRNA is colocalized with tyrosine hydroxylase-immunoreactivity in bulbospinal neurons. Neuroscience 136: 205-216, 2005.
28. Lipski J, Kanjhan R, Kruszewska B, Rong W. Properties of presympathetic neurones in the rostral ventrolateral medulla in the rat: an intracellular study in vivo. J Physiol 490: 729-744, 1996.
29. Lipski J, Kanjhan R, Kruszewska B, Smith M. Barosensitive neurons in the rostral ventrolateral medulla of the rat in vivo: morphological properties and relationship to C1 adrenergic neurons. Neuroscience 69: 601-618, 1995.
30. Minkes RK, McMahon TJ, Hood JS, Murphy WA, Coy DH, Mc-Namara DB, Kadowitz PJ. Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat. J Appl Physiol 72: 1212-1217, 1992.
31. Minson J, Arnolda L, Llewellyn-Smith I, Pilowsky P, Chalmers J. Altered c-fos in rostral medulla and spinal cord of spontaneously hypertensive rats. Hypertension 27: 433-441, 1996.
32. Miyata A, Arimura A, Dahl R, Minamino N, Uehara A, Jiang L, Culler M, Coy D. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164: 567-574, 1989.
33. Miyata A, Jiang L, Dahl RD, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170: 643-648, 1990.
34. Moon EA, Goodchild AK, Pilowsky PM. Lateralisation of projections from the rostral ventrolateral medulla to sympathetic preganglionic neurons in the rat. Brain Res 929: 181-190, 2002.
35. Murase T, Kondo K, Otake K, Oiso Y. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats. Neuroendocrinology 57: 1092-1096, 1993.
36. Nakata M, Yada T. PACAP in the glucose and energy homeostasis: physiological role and therapeutic potential. Curr Pharm Des 13: 1105-1112, 2007.
37. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27: 282-293, 1963.
38. Oshima N, Kumagai H, Onimaru H, Kawai A, Pilowsky PM, Iigaya K, Takimoto C, Hayashi K, Saruta T, Itoh H. Monosynaptic excitatory connection from the rostral ventrolateral medulla to sympathetic preganglionic neurons revealed by simultaneous recordings. Hypertens Res 31: 1445-1454, 2008.
39. Ozawa M, Aono M, Mizuta K, Moriga M, Okuma M. Central administration of PACAP stimulates gastric secretion mediated through the vagal pathway in anesthetized rats. Dig Dis Sci 42: 2552-2559, 1997.
40. Padley JR, Kumar NN, Li Q, Nguyen TB, Pilowsky PM, Goodchild AK. Central command regulation of circulatory function mediated by descending pontine cholinergic inputs to sympathoexcitatory rostral ventrolateral medulla neurons. Circ Res 100: 284-291, 2007.
41. Pettersson LM, Heine T, Verge V, Sundler F, Danielsen N. PACAP mRNA is expressed in rat spinal cord neurons. J Comp Neurol 471: 85-96, 2004.
42. Phillips JK, Goodchild AK, Dubey R, Sesiashvili E, Takeda M, Chalmers J, Pilowsky PM, Lipski J. Differential expression of catecholamine biosynthetic enzymes in the rat ventrolateral medulla. J Comp Neurol 432: 20-34, 2001. (Pubitemid 32187018)
43. Pilowsky PM, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 20: 1675-1688, 2002.
44. Pilowsky PM, Llewellyn-Smith IJ, Arnolda L, Minson J, Chalmers J. Intracellular recording from sympathetic preganglionic neurons in cat lumbar spinal cord. Brain Res 656: 319-328, 1994.
45. Robberecht P, Gourlet P, De Neef P, Woussen-Colle MC, Vandermeers-Piret MC, Vandermeers A, Christophe J. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur J Biochem 207: 239-246, 1992.
46. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43: 169-175, 2004.
47. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365: 170-175, 1993.
48. Stornetta RL, Akey PJ, Guyenet PG. Location and electrophysiological characterization of rostral medullary adrenergic neurons that contain neuropeptide Y mRNA in rat medulla. J Comp Neurol 415: 482-500, 1999.
49. Stornetta RL, Sevigny CP, Guyenet PG. Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons. J Comp Neurol 444: 191-206, 2002.
50. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BKC, Hashimoto H, Galas L, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61: 283-357, 2009.
51. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52: 269-324, 2000.